Thursday, May 23rd at 12 pm (CST/SK)

Respiratory Syncytial Virus (RSV) is a leading cause of hospitalization in infants. Learn more about the burden of RSV and clinical development of prevention strategies. Strengthen your skills as a health care practitioner in recognizing, addressing, and enhancing best practice in infant care for Canadian families.  

The objectives include: Assessing the burden of disease related to RSV in infants by reviewing the epidemiology and clinical factors for infection; reviewing novel pediatric RSV prevention strategies including long-acting monoclonal antibodies and maternal immunization, and; sharing the implementation experiences of universal nirsevimab programs in Europe.  

Presented by Dr. Athena McConnell, MD, FRCPC:

Dr. Athena McConnell is a Pediatric Infectious Disease specialist who provides clinical care related to general infectious disease problems and vaccine-preventable diseases. Dr. McConnell completed her medical school training at Queens University, pediatric residency at the University of Alberta, fellowship in Pediatric Infectious Diseases at Alberta Children's Hospital and Masters of Medical Education through the University of Calgary. She is an Associate Professor in the department of Pediatrics and is the Director, Quality and Accreditation for the College of Medicine. Prior to taking on the work of undergraduate accreditation, she held several UGME leadership roles including being the Chair of the clerkship subcommittee. She is a present member of the Faculty Undergraduate Accreditation Leads group as well as the Committee on Accreditation of Canadian Medical Schools.

This webinar is proudly sponsored by Sanofi.

REGISTER NOW